KC
Kenneth Carl Anderson
DELAYED 1 MONTH
Director
C4 Therapeutics, Inc.
Filings
1
Companies
1
Latest
Jun 1, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
C4 Therapeutics, Inc.
Kenneth Carl Anderson
Director
Option Exercise
$2.3K
1,070 sh
Jun 4 8:14 PM
Jun 1, 2026